Follow
Ran Elkon
Title
Cited by
Cited by
Year
Alternative cleavage and polyadenylation: extent, regulation and function
R Elkon, AP Ugalde, R Agami
Nature Reviews Genetics 14 (7), 496-506, 2013
8512013
eRNAs are required for p53-dependent enhancer activity and gene transcription
CA Melo, J Drost, PJ Wijchers, H van de Werken, E de Wit, JAFO Vrielink, ...
Molecular cell 49 (3), 524-535, 2013
5822013
A Pumilio-induced RNA structure switch in p27-3′ UTR controls miR-221 and miR-222 accessibility
M Kedde, M Van Kouwenhove, W Zwart, JAF Oude Vrielink, R Elkon, ...
Nature cell biology 12 (10), 1014-1020, 2010
4862010
Functional genetic screens for enhancer elements in the human genome using CRISPR-Cas9
G Korkmaz, R Lopes, AP Ugalde, E Nevedomskaya, R Han, K Myacheva, ...
Nature biotechnology 34 (2), 192-198, 2016
4622016
Transcription impacts the efficiency of mRNA translation via co-transcriptional N6-adenosine methylation
B Slobodin, R Han, V Calderone, JAFO Vrielink, F Loayza-Puch, R Elkon, ...
Cell 169 (2), 326-337. e12, 2017
4362017
The poly (A)-binding protein nuclear 1 suppresses alternative cleavage and polyadenylation sites
M Jenal, R Elkon, F Loayza-Puch, G van Haaften, U Kühn, FM Menzies, ...
Cell 149 (3), 538-553, 2012
4012012
Genome-wide in silico identification of transcriptional regulators controlling the cell cycle in human cells
R Elkon, C Linhart, R Sharan, R Shamir, Y Shiloh
Genome research 13 (5), 773-780, 2003
3882003
EXPANDER – an integrative program suite for microarray data analysis
R Shamir, A Maron-Katz, A Tanay, C Linhart, I Steinfeld, R Sharan, ...
BMC bioinformatics 6, 1-12, 2005
3732005
ATM-dependent and-independent dynamics of the nuclear phosphoproteome after DNA damage
A Bensimon, A Schmidt, Y Ziv, R Elkon, SY Wang, DJ Chen, R Aebersold, ...
Science signaling 3 (151), rs3-rs3, 2010
3422010
Transcription profiling of inner ears from Pou4f3ddl/ddl identifies Gfi1 as a target of the Pou4f3 deafness gene
R Hertzano, M Montcouquiol, S Rashi-Elkeles, R Elkon, R Yücel, ...
Human molecular genetics 13 (18), 2143-2153, 2004
2412004
BRD7 is a candidate tumour suppressor gene required for p53 function
J Drost, F Mantovani, F Tocco, R Elkon, A Comel, H Holstege, ...
Nature cell biology 12 (4), 380-389, 2010
2382010
Expander: from expression microarrays to networks and functions
I Ulitsky, A Maron-Katz, S Shavit, D Sagir, C Linhart, R Elkon, A Tanay, ...
Nature protocols 5 (2), 303-322, 2010
2162010
Apolipoprotein E4 enhances brain inflammation by modulation of the NF-κB signaling cascade
G Ophir, N Amariglio, J Jacob-Hirsch, R Elkon, G Rechavi, ...
Neurobiology of disease 20 (3), 709-718, 2005
1932005
Matrin 3 binds and stabilizes mRNA
M Salton, R Elkon, T Borodina, A Davydov, ML Yaspo, E Halperin, ...
PloS one 6 (8), e23882, 2011
1902011
E2F mediates enhanced alternative polyadenylation in proliferation
R Elkon, J Drost, G van Haaften, M Jenal, M Schrier, JAF Oude Vrielink, ...
Genome biology 13, 1-15, 2012
1802012
Alternative cleavage and polyadenylation during colorectal cancer development
AR Morris, A Bos, B Diosdado, K Rooijers, R Elkon, AS Bolijn, B Carvalho, ...
Clinical Cancer Research 18 (19), 5256-5266, 2012
1392012
p53 induces transcriptional and translational programs to suppress cell proliferation and growth
F Loayza-Puch, J Drost, K Rooijers, R Lopes, R Elkon, R Agami
Genome biology 14, 1-12, 2013
1382013
RFX transcription factors are essential for hearing in mice
R Elkon, B Milon, L Morrison, M Shah, S Vijayakumar, M Racherla, ...
Nature communications 6 (1), 8549, 2015
1372015
BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1
R Drost, KK Dhillon, H Van Der Gulden, I Van Der Heijden, I Brandsma, ...
The Journal of clinical investigation 126 (8), 2903-2918, 2016
1302016
Characterization of noncoding regulatory DNA in the human genome
R Elkon, R Agami
Nature biotechnology 35 (8), 732-746, 2017
1252017
The system can't perform the operation now. Try again later.
Articles 1–20